Title of article
Intravitreal bevacizumab for posterior capsule neovascularization
Author/Authors
Al-Mohaimeed, Mansour Al-Qassim University - College of Medicine, Saudi Arabia , Al-Gehedan, Saeed Anterior Segment Division, Saudi Arabia , Al Dhibi, Hassan King Khaled Eye Specialist Hospital - Vitreoretina Division, Saudi Arabia
From page
63
To page
65
Abstract
We report a case of rapid regression of extensive posterior capsule neovascularization in a 67-year-old diabetic male patient, who developed posterior capsule opacity with neovascularization one year post cataract surgery, after a single injection of intravitreal bevacizumab (Avastin) followed by zeodymium:YAG capsulotomy. Rapid regression of the posterior capsule neovascularization, and visual improvement was observed 9 days after the intervention. Posterior capsulotomy was performed successfully without bleeding. Prior to posterior capsulotomy, intravitreal bevacizumab can result in rapid and dramatic regression of posterior capsule neovascularization.
Keywords
Anti , vascular endothelialgrowth factor (VEGF) , Bevacizumab , Posterior capsuleneovascularization
Journal title
Saudi Journal of Ophthalmology
Journal title
Saudi Journal of Ophthalmology
Record number
2553154
Link To Document